BioSpace News Archive

BioMidwest

Hill-Rom’s Welch Allyn Introduces Connex Cardio ECG

The Welch Allyn Connex Cardio ECG helps physicians identify, manage and track conditions like heart disease and stroke by combining the clinical excellence of Mortara technology with Welch Allyn EMR connectivity expertise.

November 7, 2017

·

3 min read

Business

Ionis Pharma Reports Financial Results and Highlights for Third Quarter 2017

The Company ended the third quarter with over $1B in cash.

November 7, 2017

·

38 min read

Business

Valeant Announces Third-Quarter 2017 Results

Increased revenue in the Bausch + Lomb/International segment by 1% compared to the third quarter of 2016.

November 7, 2017

·

96 min read

Business

Ionis Names Company Co-Founder as New COO, Effective Jan. 15, 2018

In Monia’s new role, he will be responsible for transitioning research programs into development.

November 7, 2017

·

4 min read

Business

Compugen Reports Third Quarter 2017 Results

R&D expenses for the third quarter of 2017 and nine months ended September 30, 2017 were $7.6M and $21.4M, respectively, compared with $6.0M and $18.2M in the comparable periods in 2016.

November 7, 2017

·

14 min read

Appili Therapeutics Receives $1.2M USD From the Department of Defense to Advance Antibiotic Targeting Drug-Resistant Bacteria

Appili will use the funds to develop a lead compound as a preclinical candidate for its ATI-1503 antibiotic program targeting drug-resistant, Gram-negative bacteria.

November 7, 2017

·

3 min read

Policy

Newron Pharmaceuticals Announces Advisory Board Recommendations and Rett Congress Findings

At the Rett Congress, Newron’s Burden of Disease advisory board reached a consensus on the concept elicitation interviews which are being used to develop a survey that will be distributed internationally to caregivers and allied healthcare professionals.

November 7, 2017

·

8 min read

EOC Pharma Completed Series B Financing From Leading Global Investors

EOC Pharma Group today announced that it has completed a $32 million Series B financing led by Taikang Investment through Shandong State-owned Taikang Industry Development Fund (Taikang).

November 7, 2017

·

3 min read

Genetown

Seres Therapeutics Awarded Grant From CARB-X to Support Development of Microbiome Therapeutic Candidate

The CARB-X grant provides Seres with up to $2.5 million of research funding with potential for an additional $3.1 million upon completion of milestones.

November 7, 2017

·

6 min read

Business

Acerus Reports Third Quarter 2017 Financial Results

Product revenue for Q3 2017 grew to $1.6 million versus $1.4 million for Q3 2016 mainly due to increased sales of Natesto®.

November 7, 2017

·

10 min read